Skip to main content
All lobbying filings

CVS HEALTH (AND SUBSIDIARIES)

Lobbying for CVS HEALTH (AND SUBSIDIARIES) · Health Care

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $3,460,000.00 expenses · posted Apr 21, 2025

Official filing document

 Bills named in this filing 7
  • S 882
    Patients Before Middlemen Act
  • S 927
    Protecting Pharmacies in Medicaid Act
  • HR 1968
    Full-Year Continuing Appropriations and Extensions Act, 2025
  • HCONRES 14
    Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appro…
  • SCONRES 7
    An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal ye…
  • S 864
    HELP Copays Act
  • HR 2214
    DRUG Act
 Lobbying activity 6
Pharmacy

Issues related to retail pharmacy, drug pricing, and women's health.

Taxation/Internal Revenue Code

Issues related to corporate tax.

Medicare/Medicaid

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to pharmacy testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. S. 882, the Patients Before Middlemen (PBM) Act S. 927, the Protecting Pharmacies in Medicaid Act H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. S.Con.Res.7 - An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034

Insurance

Issues related to employer, small group and individual insurance markets. S. 864, the Help Ensure Lower Patients (HELP) Copays Act H.R. 2214, the Delinking Revenue from Unfair Gouging (DRUG) Act

Labor Issues/Antitrust/Workplace

Issues related to the competitive nature of the pharmacy benefit manager industry and workforce issues.

Consumer Issues/Safety/Products

Issues related to organized retail crime.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem